ACT	Adoptive Cellular Therapy
AL	Acute Leukemia
ALL	Acute Lymphocytic Leukemia
AML	Acute Myelogenous Leukemia
B-ALL	B cell Acute Lymphocytic Leukemia
BET	Bromodomain and Extra-terminal Motif
BM	Bone Marrow
CAR	Chimeric Antigen Receptor
CAR-T	Chimeric Antigen Receptor Modified T cell
CAR19-T	Anti-CD19 CAR-T
CIK	Cytokine-Induced Killer Cells
CIML	Cytokine-Induced Memory-like
CLL	Chronic Lymphocytic Leukemia
CR	Complete Remission
CRISPR	Clustered Regulatory Interspaced Short Palindromic Repeats
CRS	Cytokine Release Syndrome
Cy	Cyclophosphamide
DLBCL	Diffuse Large B-cell Lymphoma
DLI	Donor Lymphocyte Infusion
DNT	Double Negative T Cells
ER	Endoplasmic Reticulum
Flu	Fludarabine
GvHD	Graft-versus-Host Disease
GvL	Graft-versus-leukemia
HLA	Human Leukocyte Antigen
HMG	High Mobility Group
HSC	Hematopoietic Stem Cell
HSCT	Hematopoietic Stem Cell Transplant
HvG	Host-versus-Graft
KAR	Killer Activation Receptor
KIR	Killer-cell Immunoglobulin-like Receptor
MAPK	Mitogen-activated Protein Kinase
MEK	Mitogen-activated Protein Kinase Kinase
MHC	Major Histocompatibility Complex
MRD	Minimal Residual Disease
NK	Natural Killer Cells
NKR	NK Receptors
NR	Non-responder
ORR	Overall Response Rate
PEBL	Protein Expression Blocker
PD-1	Programmed Cell Death Protein 1
PD-L1	Programmed Death-Ligand
PI3K	Phosphatidylinositol 3-kinase
PR	Partial Remission
scFv	Single-Chain Variable Fragment
TALEN	Transcription Activator-Like Effector Nucleases
T-ALL	T cell Acute Lymphocytic Leukemia
TCR	T cell Receptor
TNFR	Tumor Necrosis Factor Receptor
TRAC	T cell Receptor Alpha Chain
TRAF	TNFR Associated Factors